Positron Emission Tomography (PET) Imaging Studies With NIS Reporter
NCT02907073 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2019-05-17
Summary
The goal of this proposal is to perform first-in-man evaluation of and experimental imaging agent F-18 tetrafluoroborate (BF4) or (TFB).
Conditions
Interventions
- DRUG
-
BF4
Single IV dose of 9-11 millicurie (mCi) sodium \[Fluorine-18\] radiolabeled B4\^F
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Timothy R DeGrado · Mayo Clinic
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
NCT04161781 ·Status: COMPLETED
-
PET Imaging of Ovarian Carcinoma With 18F-FSPG
NCT02872519 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
NCT00935090 ·Status: RECRUITING
-
18F-FMAU PET/CT in Imaging Patients With Advanced Cancers
NCT02079181 ·Status: TERMINATED ·Phase: NA
-
FBnTP Imaging of Breast Cancer
NCT02204462 ·Status: TERMINATED ·Phase: PHASE1
-
Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET
NCT06482307 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
NCT04752267 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Non-invasive Imaging With [18F]VM4-037
NCT00935142 ·Status: WITHDRAWN ·Phase: PHASE1
-
4FMFES-PET Imaging of Endometrial and Ovarian Cancers
NCT04823065 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PET Imaging of Intracranial Cancers With 18F-FSPG
NCT02370563 ·Status: TERMINATED ·Phase: PHASE1
-
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
NCT01806675 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients
NCT05056259 ·Status: UNKNOWN
-
PET and MRI Imaging of Brain Tumors Using [18F]PARPi
NCT04173104 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Imaging Brain Tumors With FACBC and Methionine
NCT00597246 ·Status: COMPLETED ·Phase: NA
-
[18F]Dabrafenib Molecular Imaging in Melanoma Brain Metastasis
NCT02700763 ·Status: TERMINATED ·Phase: NA
-
Validation of 18F-MISO-PET and 18F-FLT-PET
NCT00159978 ·Status: TERMINATED
-
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
NCT01717391 ·Status: COMPLETED ·Phase: PHASE2
-
[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours
NCT00323076 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations
NCT01089998 ·Status: COMPLETED ·Phase: PHASE1
-
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
NCT06503146 ·Status: RECRUITING ·Phase: PHASE2
-
18F-FDOPA PET in Neuroendocrine Tumours
NCT02431715 ·Status: NO_LONGER_AVAILABLE
-
[18F]FES PET/CT in Endocrine Refractory Breast Cancer
NCT02409316 ·Status: COMPLETED ·Phase: PHASE2
-
18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors
NCT04258592 ·Status: TERMINATED ·Phase: PHASE1
-
F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer
NCT01985971 ·Status: COMPLETED ·Phase: NA
-
F-Tryptophan PET/CT in Human Cancers
NCT05556473 ·Status: RECRUITING ·Phase: PHASE1